TickerFactsScreenerDevelopers

Telomir Pharmaceuticals, Inc. (TELO) — Net Income

Annual figures by fiscal year, from SEC filings.

2022: -$854.1K2023: -$13.07M2024: -$16.53M2025: -$10.41M-$10.41M
2022Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$10.41M+37.0%
2024-$16.53M-26.5%
2023-$13.07M-1430.4%
2022-$854.1K—